Company
United StatesPublic company, NASDAQ: PBYIPuma Biotechnology, Inc. (NASDAQ: PBYI), Los Angeles, CA – FDA Inspections
Inspection records and compliance data for Puma Biotechnology, Inc. in Los Angeles, California. 3 FDA inspections on record, 1 Form 483, last inspected July 20, 2022. Publicly traded as NASDAQ: PBYI.
Company Profile
This profile covers Puma Biotechnology, Inc. based in Los Angeles, California, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected March 17, 2017. Last inspected July 20, 2022.
Most cited issue areas
- General responsibilities of sponsors1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 20, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1180087 |
| May 24, 2019 | VAI | Human Drugs · Bioresearch Monitoring | 1090911 |
| March 17, 2017 | NAI | Human Drugs · Bioresearch Monitoring | 1004204 |
FDA documents
Form 483s (1)
People (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Puma Biotechnology, Inc.
Stock ticker
PBYI
Exchange
NASDAQ
Share price
$8.08
Market cap
$417.7M
Price as of
November 13, 2026
FEI Number
3011065073
Address
10880 Wilshire Blvd Ste 2150, Los Angeles, California 90024, United States
Country
United States
ID: 003e999e-88e3-442b-bea7-8343b307740f